These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37762422)

  • 21. A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re-evaluating primer sequences.
    Kim SM; Noh ES; Park JH; Park HD; Lee SY; Jang JH; Cho SY
    Ann Hum Genet; 2022 Nov; 86(6):361-368. PubMed ID: 36000290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Growth Induction in Mucopolysaccharidosis IVA Mouse.
    Rintz E; Herreño-Pachón AM; Celik B; Nidhi F; Khan S; Benincore-Flórez E; Tomatsu S
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
    Lyseng-Williamson KA
    BioDrugs; 2014 Oct; 28(5):465-75. PubMed ID: 25200032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase Produced in Pichia pastoris as Potential Enzyme for Mucopolysaccharidosis IVA Treatment.
    Rodríguez-López A; Pimentel-Vera LN; Espejo-Mojica AJ; Van Hecke A; Tiels P; Tomatsu S; Callewaert N; Alméciga-Díaz CJ
    J Pharm Sci; 2019 Aug; 108(8):2534-2541. PubMed ID: 30959056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia.
    Khedhiri S; Chkioua L; Bouzidi H; Dandana A; Ben Turkia H; Miled A; Laradi S
    Pathol Biol (Paris); 2009 Jul; 57(5):392-7. PubMed ID: 18584975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Various cells retrovirally transduced with N-acetylgalactosoamine-6-sulfate sulfatase correct Morquio skin fibroblasts in vitro.
    Toietta G; Severini GM; Traversari C; Tomatsu S; Sukegawa K; Fukuda S; Kondo N; Tortora P; Bordignon C
    Hum Gene Ther; 2001 Nov; 12(16):2007-16. PubMed ID: 11686941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of GALNS gene mutation in thirty-eight Chinese patients with mucopolysaccharidosis type IVA].
    Ye J; Lei HL; Zhang HW; Qiu WJ; Han LS; Wang Y; Li XY; Gu XF
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):414-9. PubMed ID: 24120057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.
    Leong HY; Abdul Azize NA; Chew HB; Keng WT; Thong MK; Mohd Khalid MKN; Hung LC; Mohamed Zainudin N; Ramlee A; Md Haniffa MA; Yakob Y; Ngu LH
    Orphanet J Rare Dis; 2019 Jun; 14(1):143. PubMed ID: 31200731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bio-Plex immunoassay measuring the quantity of lysosomal
    Chuang CK; Lin HY; Wang TJ; Huang SF; Lin SP
    BMJ Open; 2017 Jul; 7(7):e014410. PubMed ID: 28710204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a fluorometric microtiter plate based enzyme assay for MPS IVA (Morquio type A) using dried blood spots.
    Ullal AJ; Millington DS; Bali DS
    Mol Genet Metab Rep; 2014; 1():461-464. PubMed ID: 27896123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene.
    Li R; Baskfield A; Beers J; Zou J; Liu C; Alméciga-Díaz CJ; Zheng W
    Stem Cell Res; 2019 Apr; 36():101408. PubMed ID: 30797135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Proteomic Analysis in Morquio A Disease.
    Álvarez JV; Bravo SB; Chantada-Vázquez MP; Barbosa-Gouveia S; Colón C; López-Suarez O; Tomatsu S; Otero-Espinar FJ; Couce ML
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elosulfase alfa.
    Haddley K
    Drugs Today (Barc); 2014 Jul; 50(7):475-83. PubMed ID: 25101330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction of an adenoassociated, viral derived, expression vector to correct the genetic defect in Morquio A disease].
    Gutiérrez MA; García-Vallejo F; Tomatsu S; Cerón F; Alméciga-Díaz CJ; Domínguez MC; Barrera LA
    Biomedica; 2008 Sep; 28(3):448-59. PubMed ID: 19034368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy.
    Donida B; Marchetti DP; Biancini GB; Deon M; Manini PR; da Rosa HT; Moura DJ; Saffi J; Bender F; Burin MG; Coitinho AS; Giugliani R; Vargas CR
    Biochim Biophys Acta; 2015 May; 1852(5):1012-9. PubMed ID: 25701642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients.
    Tomatsu S; Filocamo M; Orii KO; Sly WS; Gutierrez MA; Nishioka T; Serrato OP; Di Natale P; Montaño AM; Yamaguchi S; Kondo N; Orii T; Noguchi A
    Hum Mutat; 2004 Aug; 24(2):187-8. PubMed ID: 15241807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosing mucopolysaccharidosis IVA.
    Wood TC; Harvey K; Beck M; Burin MG; Chien YH; Church HJ; D'Almeida V; van Diggelen OP; Fietz M; Giugliani R; Harmatz P; Hawley SM; Hwu WL; Ketteridge D; Lukacs Z; Miller N; Pasquali M; Schenone A; Thompson JN; Tylee K; Yu C; Hendriksz CJ
    J Inherit Metab Dis; 2013 Mar; 36(2):293-307. PubMed ID: 23371450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months.
    Nakamura-Utsunomiya A; Nakamae T; Kagawa R; Karakawa S; Sakata S; Sakura F; Tani C; Matsubara Y; Ishino T; Tajima G; Okada S
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32024277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.
    Akyol MU; Alden TD; Amartino H; Ashworth J; Belani K; Berger KI; Borgo A; Braunlin E; Eto Y; Gold JI; Jester A; Jones SA; Karsli C; Mackenzie W; Marinho DR; McFadyen A; McGill J; Mitchell JJ; Muenzer J; Okuyama T; Orchard PJ; Stevens B; Thomas S; Walker R; Wynn R; Giugliani R; Harmatz P; Hendriksz C; Scarpa M; ;
    Orphanet J Rare Dis; 2019 Jun; 14(1):137. PubMed ID: 31196221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.